Neutrophil migration participates in the side effect of recombinant human tissue plasminogen activator
CNS Neuroscience & Therapeutics · 2024
DOI: 10.1111/cns.14825 ↗Kurz gefasst
Fachartikel in der Zeitschrift CNS Neuroscience & Therapeutics, 2024. Verfasst von Yuyou Huang und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology and Institute of Cerebrovascular Diseases Research, Xuanwu Hospital of Capital Medical University, Beijing, China. Hauptthemen laut MEDLINE: Tissue Plasminogen Activator, Neutrophils, Recombinant Proteins, Fibrinolytic Agents. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 29 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Beijing Municipal Natural Science Foundation.
Abstract (Originalsprache)
Aims
Ischemic stroke remains a challenge in medical research because of the limited treatment options. Recombinant human tissue plasminogen activator (rtPA) is the primary treatment for recanalization. However, nearly 50% of the patients experience complications that result in ineffective reperfusion. The precise factors contributing to ineffective reperfusion remain unclear; however, recent studies have suggested that immune cells, notably neutrophils, may influence the outcome of rtPA thrombolysis via mechanisms such as the formation of neutrophil extracellular traps. This study aimed to explore the nonthrombolytic effects of rtPA on neutrophils and highlight their contribution to ineffective reperfusion.
Methods
We evaluated the effects of rtPA treatment on middle cerebral artery occlusion in rats. We also assessed neutrophil infiltration and activation after rtPA treatment in vitro and in vivo in a small cohort of patients with massive cerebral ischemia (MCI). Results rtPA increased neutrophil infiltration into the brain microvessels and worsened blood–brain barrier damage during ischemia. It also increased the neutrophil counts of the patients with MCI.
Conclusion
Neutrophils play a crucial role in promoting ischemic injury and blood–brain barrier disruption, making them potential therapeutic targets.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Neurology and Institute of Cerebrovascular Diseases Research, Xuanwu Hospital of Capital Medical University, Beijing, China.
- Beijing Institute for Brain Disorders, Capital Medical University, Beijing, China.
ORCID-Profile: Yuyou Huang, Yumin Luo
Förderung
- National Natural Science Foundation of China
- Beijing Municipal Natural Science Foundation
Zitieren
APA
Huang, Y., Han, Z., Shen, T., Zheng, Y., Yang, Z., Fan, J., Wang, R., Yan, F., Tao, Z., Luo, Y., & Liu, P. (2024). Neutrophil migration participates in the side effect of recombinant human tissue plasminogen activator. CNS Neuroscience & Therapeutics. https://doi.org/10.1111/cns.14825
Vancouver
Huang Y, Han Z, Shen T, Zheng Y, Yang Z, Fan J, et al. Neutrophil migration participates in the side effect of recombinant human tissue plasminogen activator. CNS Neuroscience & Therapeutics. 2024. doi:10.1111/cns.14825
BibTeX
@article{Huang2024,
author = {Huang, Yuyou and Han, Ziping and Shen, Tong and Zheng, Yangmin and Yang, Zhenhong and Fan, Junfen and Wang, Rongliang and Yan, Feng and Tao, Zhen and Luo, Yumin and Liu, Ping},
title = {Neutrophil migration participates in the side effect of recombinant human tissue plasminogen activator},
journal = {CNS Neuroscience & Therapeutics},
year = {2024},
doi = {10.1111/cns.14825}
}
EUVIMED